ArticleJournal of transplantation2009

The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation.

Monika Conchon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.